NCT02704962View on ClinicalTrials.gov

Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

PHASE4CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Schizophrenia
Interventions
DRUG

full-dose olanzapine

trifluoperazine 5mg/d

Trial Locations (2)

802

Kai-Suan Psychiatric Hospital, Kaohsiung City

Unknown

Kai-Suan Psychiatric Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Department of Health, Executive Yuan, R.O.C. (Taiwan)

OTHER_GOV

lead

Kaohsiung Kai-Suan Psychiatric Hospital

OTHER_GOV

NCT02704962 - Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine | Biotech Hunter | Biotech Hunter